Search hospitals > Virginia > Burke
Kaiser Permanente-Burke Medical Center
Claim this profileBurke, Virginia 22015
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
33 reported clinical trials
1 medical researcher
Summary
Kaiser Permanente-Burke Medical Center is a medical facility located in Burke, Virginia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Kaiser Permanente-Burke Medical Center is involved with conducting 33 clinical trials across 62 conditions. There are 1 research doctors associated with this hospital, such as Leon C. Hwang.Area of expertise
1Cancer
Global LeaderHER2 positive
Stage II
Stage III
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Clinical Trials running at Kaiser Permanente-Burke Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Recurrence
Colon Cancer
Adenoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Burke Medical Center?
Kaiser Permanente-Burke Medical Center is a medical facility located in Burke, Virginia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Kaiser Permanente-Burke Medical Center is involved with conducting 33 clinical trials across 62 conditions. There are 1 research doctors associated with this hospital, such as Leon C. Hwang.